Simon Sieber

Dr. Simon Sieber

Department of chemistry, University of Zurich, Zürich, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
CJChristian Jenul
Christian Jenul
SSSimon Sieber
Simon Sieber
CDChristophe Daeppen
Christophe Daeppen
AMAnugraha Mathew
Anugraha Mathew
MLMartina Lardi
Martina Lardi
LELeo Eberl
Leo Eberl
Members of the diazeniumdiolate class of natural compounds show potential for drug development because of their antifungal, antibacterial, antiviral, and antitumor activities. Yet, their biosynthesis has remained elusive to date. Here, we identify a gene cluster directing the biosynthesis of the diazeniumdiolate compound fragin in Burkholderia cenocepacia H111. We provide evidence that fragin is a metallophore and that metal chelation is the molecular basis of its antifungal activity. A subset of the fragin biosynthetic genes is involved in the synthesis of a previously undescribed cell-to-cell signal molecule, valdiazen. RNA-Seq analyses reveal that valdiazen controls fragin biosynthesis and affects the expression of more than 100 genes. Homologs of the valdiazen biosynthesis genes are found in various bacteria, suggesting that valdiazen-like compounds may constitute a new class of signal molecules. We use structural information, in silico prediction of enzymatic functions and biochemical data to propose a biosynthesis route for fragin and valdiazen.

15 March 2016 in The ISME Journal
Verified
Journal Article
Closed access
MPMarta Pinto-Carbó
Marta Pinto-Carbó
SSSimon Sieber
Simon Sieber
SDSteven Dessein
Steven Dessein
TWThomas Wicker
Thomas Wicker
BVBrecht Verstraete
Brecht Verstraete
ACAurélien Carlier
Aurélien Carlier
Bacteria of the genus Burkholderia establish an obligate symbiosis with plant species of the Rubiaceae and Primulaceae families. The bacteria, housed within the leaves, are transmitted hereditarily and have not yet been cultured. We have sequenced and compared the genomes of eight bacterial leaf nodule symbionts of the Rubiaceae plant family. All of the genomes exhibit features consistent with genome erosion. Genes potentially involved in the biosynthesis of kirkamide, an insecticidal C7N aminocyclitol, are conserved in most Rubiaceae symbionts. However, some have partially lost the kirkamide pathway due to genome erosion and are unable to synthesize the compound. Kirkamide synthesis is therefore not responsible for the obligate nature of the symbiosis. More importantly, we find evidence of intra-clade horizontal gene transfer (HGT) events affecting genes of the secondary metabolism. This indicates that substantial gene flow can occur at the early stages following host restriction in leaf nodule symbioses. We propose that host-switching events and plasmid conjugative transfers could have promoted these HGTs. This genomic analysis of leaf nodule symbionts gives, for the first time, new insights in the genome evolution of obligate symbionts in their early stages of the association with plants.

10 September 2020 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
ISInga S. Shchelik
Inga S. Shchelik
SSSimon Sieber
Simon Sieber
KGKarl Gademann
Karl Gademann
New strategies to efficiently treat bacterial infections are crucial to circumvent the increase of resistant strains and to mitigate side effects during treatment. Skin and soft tissue infections represent one of the areas suffering the most from these resistant strains. We developed a new drug delivery system composed of the green algae, Chlamydomonas reinhardtii, which is generally recognized as safe, to target specifically skin diseases. A two‐step functionalization strategy was used to chemically modify the algae with the antibiotic vancomycin. Chlamydomonas reinhardtii was found to mask vancomycin and the insertion of a photocleavable linker was used for the release of the antibiotic. This living drug carrier was evaluated in presence of Bacillus subtilis and, only upon UVA1‐mediated release, growth inhibition of bacteria was observed. These results represent one of the first examples of a living organism used as a drug delivery system for the release of an antibiotic by UVA1‐irradiation.

1 June 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SSSimon Sieber
Simon Sieber
ACAurélien Carlier
Aurélien Carlier
MNMarkus Neuburger
Markus Neuburger
GGGiselher Grabenweger
Giselher Grabenweger
LELeo Eberl
Leo Eberl
KGKarl Gademann
Karl Gademann

6 January 2014 in Journal of Natural Products
Verified
Journal Article
Closed access
CPCyril Portmann
Cyril Portmann
SSSimon Sieber
Simon Sieber
SWSilvan Wirthensohn
Silvan Wirthensohn
JBJudith F. Blom
Judith F. Blom
LSLaeticia Da Silva
Laeticia Da Silva
KGKarl Gademann
Karl Gademann

28 January 2020 in Journal of Natural Products
Verified
Journal Article
Closed access
SSSimon Sieber
Simon Sieber
SGSimone M. Grendelmeier
Simone M. Grendelmeier
LHLonnie A. Harris
Lonnie A. Harris
DMDouglas A. Mitchell
Douglas A. Mitchell
KGKarl Gademann
Karl Gademann